[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate

C22H29NO4 — CID 162940343

IUPAC[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate
SMILESC=C1[C@H]2C[C@@H]3[C@H]4N5C[C@]6(C)CCC[C@@]47[C@@H]6[C@@H]5[C@@H](O)[C@]3([C@@H]1O)[C@H]7[C@@H]2OC(C)=O
InChIInChI=1S/C22H29NO4/c1-9-11-7-12-17-21-6-4-5-20(3)8-23(17)13(15(20)21)19(26)22(12,18(9)25)16(21)14(11)27-10(2)24/h11-19,25-26H,1,4-8H2,2-3H3/t11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22+/m1/s1
InChIKeyRINGSRWVMFQHRI-UBUXLEJNSA-N
MW371.48 g/mol
LogP1.33
Rot. Bonds1

About [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate

[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate (PubChem CID 162940343) has the molecular formula C22H29NO4 and a molecular weight of 371.48 g/mol. Its IUPAC name is [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate.

Molecular Properties

Compound Name[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate
PubChem CID162940343
Molecular FormulaC22H29NO4
Molecular Weight371.48 g/mol
Exact Mass371.21
IUPAC Name[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate
SMILESC=C1[C@H]2C[C@@H]3[C@H]4N5C[C@]6(C)CCC[C@@]47[C@@H]6[C@@H]5[C@@H](O)[C@]3([C@@H]1O)[C@H]7[C@@H]2OC(C)=O
InChIInChI=1S/C22H29NO4/c1-9-11-7-12-17-21-6-4-5-20(3)8-23(17)13(15(20)21)19(26)22(12,18(9)25)16(21)14(11)27-10(2)24/h11-19,25-26H,1,4-8H2,2-3H3/t11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22+/m1/s1
InChIKeyRINGSRWVMFQHRI-UBUXLEJNSA-N
XLogP1.33
TPSA70.00 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds1
Heavy Atoms27
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500371.48
LogP ≤ 51.33
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate?
The IUPAC name of [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate (CID 162940343) is [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate.
What is the SMILES notation for [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate?
The canonical SMILES for [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate is C=C1[C@H]2C[C@@H]3[C@H]4N5C[C@]6(C)CCC[C@@]47[C@@H]6[C@@H]5[C@@H](O)[C@]3([C@@H]1O)[C@H]7[C@@H]2OC(C)=O.
What is the InChIKey of [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate?
The InChIKey is RINGSRWVMFQHRI-UBUXLEJNSA-N. The full InChI is InChI=1S/C22H29NO4/c1-9-11-7-12-17-21-6-4-5-20(3)8-23(17)13(15(20)21)19(26)22(12,18(9)25)16(21)14(11)27-10(2)24/h11-19,25-26H,1,4-8H2,2-3H3/t11-,12-,13-,14-,15-,16+,17-,18-,19-,20+,21+,22+/m1/s1.
What are the key properties of [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate?
[(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate has a molecular weight of 371.48 g/mol, XLogP of 1.33, 1 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,5R,8R,9S,11R,13R,14S,15S,16R,17R,18S,19R)-13,15-dihydroxy-5-methyl-12-methylidene-7-azaheptacyclo[9.6.2.01,8.05,17.07,16.09,14.014,18]nonadecan-19-yl] acetate is sourced from PubChem (CID 162940343), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).